Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,138.80
(
-0.49%
)
US TECH 100
26,356.00
(
-0.80%
)
Dow Jones
49,141.93
(
-0.34%
)
Brent Oil
104.41
(
2.25%
)
Bitcoin
76,259.97
(
-1.44%
)
News Focus
News Focus
Post# of 823421
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

HyGro

Send PM Follow Ignore
Followers 24
Posts 4179
Boards Moderated 0
Alias Born 12/18/2019

HyGro

Re: Roman516 post# 521242

Thursday, 10/13/2022 2:55:16 AM

Thursday, October 13, 2022 2:55:16 AM

Post# of 823421
And you missed that NWBO announced they failed to meet the original primary endpoint of their Phase 3 clinical trial. No biotech investors bought the TLD from that point on and the share price showed no positive response to the TLD.
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News